儿童疫苗多重抗体检测方法的开发与应用
研究开发了一种儿童疫苗多重检测法(PVMA),可同时检测乙肝、b型流感嗜血杆菌、白喉、破伤风、百日咳、风疹和呼吸道合胞病毒(RSV)抗体。与酶联免疫吸附试验(ELISA)相比,PVMA高度敏感、特异、可重复且准确,评估队列所需时间减半,成本仅略高。用PVMA评估HIV疫苗对常规儿童疫苗的干扰,发现疫苗组与安慰剂组抗体浓度无实质性差异。
要点
- PVMA可同时检测多种儿童疫苗抗体,敏感、特异、可重复且准确。
- 与ELISA相比,PVMA评估队列时间减半,成本仅略高。
- HIV疫苗接种未破坏常规儿童疫苗诱导的抗体应答。
核心结论
- PVMA是一种可靠的高通量技术,所需样本量少,可同时检测多种抗体浓度,是大规模队列中检测疫苗诱导抗体应答的有效ELISA替代方法。
研究设计与样本
- 研究开发了儿童疫苗多重检测法(PVMA),并与ELISA比较抗体浓度测定;利用已完成的小儿艾滋病临床试验组(PACTG)方案230和326中的婴儿HIV疫苗作为示例,评估疫苗干扰。
主要发现
- PVMA与ELISA测定的抗体浓度比较显示PVMA高度敏感、特异、可重复且准确。
- PVMA评估一个队列所需时间是ELISA的一半,成本仅略高。
- 在PACTG 230和326的婴儿HIV疫苗示例中,疫苗组与安慰剂组抗体浓度无实质性差异。
关键数值与推荐
- PVMA可同时检测针对乙肝、b型流感嗜血杆菌、白喉、破伤风、百日咳、风疹和呼吸道合胞病毒(RSV)疫苗的抗体。
临床怎么用
- PVMA可作为ELISA的有效替代方法,用于大规模队列中疫苗诱导抗体应答的检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Because vaccine co-administration can affect elicited immune responses, it is important to evaluate new vaccines in the context of pre-existing vaccination schedules. This is particularly necessary for new pediatric vaccines, as the World Health Organization's infant immunization program already schedules several vaccines to be administered during the first months of life. To facilitate the assessment of inter-vaccine interference, we developed a pediatric vaccine multiplex assay (PVMA) to simultaneously measure antibodies against vaccines commonly administered to infants, including hepatitis B, Haemophilus influenzae type B, diphtheria, tetanus, pertussis, rubella, and respiratory syncytial virus (RSV). Comparison of antibody concentrations determined by enzyme-linked immunosorbent assays (ELISAs) and the PVMA demonstrated that the PVMA is highly sensitive, specific, reproducible, and accurate. Moreover, the PVMA requires half the time to assess a cohort compared to ELISAs, and only costs marginally more. Demonstrating the utility of the assay, we employed the PVMA to assess vaccine interference in the setting of a candidate vaccine, using the infant HIV vaccines from the completed Pediatric AIDS Clinical Trials Group (PACTG) protocols 230 and 326 as examples. There was no substantial difference in antibody concentrations between vaccine and placebo recipients, which suggests that HIV vaccination did not disrupt antibody responses elicited by routine pediatric vaccines. Thus, the PVMA is a reliable, high-throughput technique that requires minimal sample volume to measure multiple antibody concentrations concurrently, and is an efficient alternative to ELISAs for the measurement of vaccine-elicited antibody responses in large cohorts.
引用
- Itell HL, McGuire EP, Muresan P, et al. Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines. Vaccine. 2018. PMID: 30087048. doi:10.1016/j.vaccine.2018.07.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。